Semaglutide is a medication used to treat type 2 diabetes and obesity. It primarily works by mimicking the action of a hormone in the body called glucagon-like peptide-1 (GLP-1) to lower blood sugar levels and regulate body weight.
Semaglutide not only helps control blood sugar but also slows gastric emptying and increases satiety, aiding in weight management. In multiple clinical trials, semaglutide has demonstrated significant blood sugar-lowering and weight-loss effects.
Semaglutide is a GLP-1 receptor agonist; by mimicking the action of GLP-1, it promotes insulin secretion and inhibits glucagon release, thereby effectively lowering blood sugar levels.
Common side effects associated with semaglutide use include nausea, vomiting, diarrhea, and constipation. Generally, these side effects are more pronounced during the initial phase of treatment but tend to subside over time.
Semaglutide is typically administered via subcutaneous injection once weekly. Specific dosages and usage instructions should be determined by a healthcare professional based on the patient's individual condition.
Semaglutide is indicated for patients with type 2 diabetes whose blood sugar cannot be adequately controlled by other oral antidiabetic medications, as well as for patients with obesity who have a high body mass index (BMI) and associated health issues.